InvestorsHub Logo
Followers 22
Posts 7075
Boards Moderated 0
Alias Born 05/14/2011

Re: Foose post# 606

Friday, 09/25/2020 9:40:32 PM

Friday, September 25, 2020 9:40:32 PM

Post# of 892
Cool Foose. Nice timing. Got some background data down below.

On a scheduling note, just at the beginning of this CALENDAR YEAR, our board of directors were telling us the second half of 2020 was going to be our rocket-to-the moon. So I figured we'd be at least to countdown on the blast-off by now.

AHHH, they were talking about TYME's FISCAL YEAR 2020, my reckoning has the second quarter just coming to an end Wednesday coming up. Be glad to end this one. We do seem on-time in the timeline laid out in the corporate presentation updated every funding cycle.

First clinical report on both Panceratic Cancer trials, maybe the Ewings Sarcoma as wll. Got some links to our trials on database managed CLINICAL TRIALS.gov site down below.

Before that, of the five trials list raised all sorts of problems and died on the vine. Successful breast cancer trial, without enough funding to properly complete. Da.... shame on that. Actual these first three links are three sides of the coin on that stalled, under-fund breast cancer study.
***************************************************
Links on BREAST CANCER
(1) Here is our wunder-ful wunder-ful positive testimonial link:

https://people.com/bodies/head-of-the-class-khrystyne-haje-recovered-stage-iv-breast-cancer/

(2) This link will get you a fairly succinct piece of where we were viewed ahh, negatively.

https://ihatebreastcancer.wordpress.com/2017/04/13/khrystyne-haje-and-the-sm-88-story/.

(3) This third one is the market perspective on the downfall that led to one of our founder's, Red Bank Mike Demurgian's departure.
https://www.fool.com/investing/2019/01/18/heres-why-tyme-technologies-fell-35-on-friday.aspx#:~:text=Shares%20of%20Tyme%20Technologies%20(NASDAQ,patients%20with%20advanced%20pancreatic%20cancer.
***************************************************
Link to Clinical trials.gov site. Will takes a little time to practice with on what you play around trying to dig through the fields that will raise some questions in your mind. My method to use hitting on our Investor Relations rep, Brian Gill.

(1) https://clinicaltrials.gov/ct2/results?cond=&term=sm-88&cntry=&state=&city=&dist=&number=Link

That'll get you to status tables for all five. Play around on the top tool bar to view the fields you want. This next link is pretty cool to play with. Shows one study (the CT number for Clinical Trial ID reference).

You can compare the versions of all the data tables on each trial. I encourage you and all to play with it.

(2) https://clinicaltrials.gov/ct2/history//NCT03512756
*******************************************************
So we're about to enter the second half of TYME's FY 2020. Blast off supposed to happen between now and March. AHHHH.
Frustrating.
GLTUA. Need to get back over a buck and we will.